AxoSim Inc., is in the field of development and application of live biometric human drug discovery platforms for neurological diseases announced yesterday (October 24) the acquisition of microBrain-associated assets of Vyant Bio’s Stemonix subsidiary.
The …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
